(MENAFN- GlobeNewsWire - Nasdaq) SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona's chief executive officer, will present a corporate update on Tuesday, March 19 at 5:00 pm ET and host one-on-one meetings during the Stifel 2024 Virtual CNS Days taking place on March 19-20, 2024.
The presentation will be webcast live and may be accessed via a link in the News section of the Neurona website under Events . An archived copy of the webcast will be available on the website for approximately 30 days after the event.
About Neurona Therapeutics
Neurona is focused on developing regenerative cell therapy candidates with single-dose curative potential. Neurona's investigational allogeneic, off-the-shelf, cell therapy candidates are designed to provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona, visit .
Investor and Media Contacts:
Sylvia Wheeler
Wheelhouse LSA
...
| Elizabeth Wolffe, Ph.D.
Wheelhouse LSA
...
|
MENAFN12032024004107003653ID1107968854
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment